Ep0215 125 — Tacoma, Washington

Ep0215 125 is a clinical research site located in Tacoma, Washington, United States 98405.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ep0215 125 has participated in 1 clinical trials.

Therapeutic areas: Dravet Syndrome, Lennox Gastaut Syndrome, Epileptic Encephalopathy.

Sponsors: Zogenix, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tacoma

Browse all research sites in Washington · View every site in Tacoma

• Tacoma General Hospital
• VA Puget Sound HCS University of Washington
• VA Puget Sound Health Care System, American Lake Division
• VA Puget Sound Health Care System, Tacoma
• St. Clare Hospital
• MultiCare Good Samaritan Hospital
• MultiCare Regional Cancer Center at Tacoma General Hospital
• Allenmore Hospital
• Mary Bridge Children's Hospital and Health Center
• Mary Bridge Children's Hospital and Health Center - Tacoma
• VA Puget Sound Health Care System American Lake Division, Tacoma, WA
• Multicare Research Institute/Tacoma General Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0215 125?

Ep0215 125 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0215 125 conducted?

Ep0215 125 has 1 clinical trials on record. Their work covers Dravet Syndrome, Lennox Gastaut Syndrome, Epileptic Encephalopathy.

Is Ep0215 125 accredited by Crixeo Clinical Trials?

Ep0215 125 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0215 125?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.